Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Up-regulation of GSTT1 in serous ovarian cancer associated with resistance to TAXOL / carboplatin
Authors
Keywords
-
Journal
Journal of Ovarian Research
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-17
DOI
10.1186/s13048-021-00873-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glutathione S-Transferases in Cancer
- (2021) Rahul Raj Singh et al. Antioxidants
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Multiple Topoisomerase I (TopoI), Topoisomerase II (TopoII) and Tyrosyl-DNA Phosphodiesterase (TDP) inhibitors in the development of anticancer drugs
- (2020) Emma Baglini et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line
- (2018) Ling Fu et al. ANTI-CANCER DRUGS
- The multifaceted role of glutathione S-transferases in cancer
- (2018) Anupam Chatterjee et al. CANCER LETTERS
- Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
- (2018) Shan-Shan Li et al. Journal of Gynecologic Oncology
- GSTM1, GSTT1, and GSTP1 polymorphisms and colorectal cancer risk in Polish nonsmokers
- (2018) Justyna Klusek et al. Oncotarget
- Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer
- (2018) Alison E. Freimund et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The molecular mechanisms of chemoresistance in cancers
- (2017) Hua-Chuan Zheng Oncotarget
- Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile
- (2016) Deolinda Pereira et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer
- (2016) Shinichi Komiyama et al. International Journal of Clinical Oncology
- GSTT1 Polymorphism and the Risk of Developing Prostate Cancer
- (2014) T.-B. Zhou et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Dual Glutathione-S-Transferase-θ1 and -μ1 Gene Deletions Determine Imatinib Failure in Chronic Myeloid Leukemia
- (2014) A Davies et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association between Glutathione S-Transferase T1, M1, and P1 Genotypes and the Risk of Colorectal Cancer
- (2014) Ning Cong et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- A novel CyclinE/CyclinA-CDK Inhibitor targets p27Kip1 degradation, cell cycle progression and cell survival: Implications in cancer therapy
- (2013) Lu Dai et al. CANCER LETTERS
- Mycoplasma fermentans Inhibits the Activity of Cellular DNA Topoisomerase I by Activation of PARP1 and Alters the Efficacy of Its Anti-Cancer Inhibitor
- (2013) Reuven Afriat et al. PLoS One
- Glutathione transferases, regulators of cellular metabolism and physiology
- (2012) Philip G. Board et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy
- (2012) Ignacio Romero et al. ENDOCRINOLOGY
- The autoantigen DNA topoisomerase I interacts with chemokine receptor 7 and exerts cytokine-like effects on dermal fibroblasts
- (2011) Julie Arcand et al. ARTHRITIS AND RHEUMATISM
- GSTM1 and GSTT1 Copy Number Variation in Population-based Studies of Endometrial Cancer Risk
- (2011) S. Karageorgi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Glutathione transferases and development of new principles to overcome drug resistance
- (2010) Andrea Sau et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started